Krystal Biotech (NASDAQ:KRYS) said it has generated positive interim clinical results for its inhaled cystic fibrosis (CF) ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutationsKB407 transduction confirmed in all ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespect ...

Detailed price information for Sionna Therapeutics Inc (SION-Q) from The Globe and Mail including charting and trades.

The company in 2026 is seeking approval from global regulators for Casgevy and two cystic fibrosis drugs in younger patients.

Krystal Biotech, Inc. KRYS expects preliminary unaudited net product revenues of $106-$107 million from lead drug Vyjuvek in ...

Residual CFTR function in cystic fibrosis was associated with better glucose tolerance and insulin secretion, with CFTR ...

The blood-brain and blood-retinal barriers are protective systems that prevent harmful substances from entering the brain and ...

As we age, we don't recover from injury or illness like we did when we were young. But new research from UCSF has found gene ...

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...

Cholera, a severe bacterial infection that causes diarrhea and kills if untreated, can be defeated with a diet high in ...

Researchers at the Indian Institute of Science (IISc), with collaborators from the Institute of Mathematical Sciences (IMSc), ...